Weak Emerging Markets And European Pressures Will Drag Down Value

Key Takeaways

• Weakness in emerging markets and demographic shifts in developed economies threaten long-term revenue growth and limit prospects for legacy brands.
  
• Rising competition and higher costs from innovation, marketing, and geopolitical factors are putting sustained pressure on profit margins and earnings stability.
  
• Accelerated innovation, premiumization, and digital expansion are strengthening brand equity, broadening market reach, and positioning Beiersdorf for sustained outperformance and margin growth.

Catalysts

Manufactures and distributes consumer goods in Europe, the United States, Africa, Asia, and Australia.

• The sluggish growth in emerging and mass markets―formerly crucial drivers for Beiersdorf―signals a long-term contraction in the addressable market, with value growth dropping sharply from double-digits to mid-single digits, and volume growth in emerging markets reducing from mid-single digits to nearly zero; this persistent weakness will likely constrain future revenue expansion and erode top-line growth.
  
• Intensifying competition from agile local brands, direct-to-consumer upstarts, and private label offerings has diminished Beiersdorf's pricing power, leading to delistings and retail pushbacks in key European markets, and is expected to put ongoing downward pressure on both revenue growth and net profit margins over the coming years.
  
• Demographic changes in developed markets, particularly an aging population and stagnating growth among younger demographics, structurally limit the long-term prospects for legacy brands like NIVEA and Eucerin, implying a persistent drag on top-line growth and volume over the next decade.
  
• Continued reliance on heavy innovation spend and aggressive marketing investments to maintain share and support major new launches in the face of weak organic growth is likely to compress net margins over time, especially as ROI on incremental spend appears to be stagnating even as cost of doing business rises across digital, e-commerce, and regulatory compliance channels.
  
• Ongoing geopolitical instability, trade barriers, and tariff risks (notably for products manufactured in Switzerland and exports to the US) expose Beiersdorf to unpredictable cost increases, currency volatility, and supply chain disruptions, ultimately threatening earnings stability and leading to potentially lower profitability for international operations.

Beiersdorf Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• This narrative explores a more pessimistic perspective on Beiersdorf compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
• The bearish analysts are assuming Beiersdorf's revenue will grow by 1.7% annually over the next 3 years.
• The bearish analysts assume that profit margins will shrink from 9.5% today to 8.7% in 3 years time.
• The bearish analysts expect earnings to reach €895.9 million (and earnings per share of €4.52) by about April 2029, down from €939.0 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as €1.1 billion.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 18.7x on those 2029 earnings, up from 16.8x today. This future PE is greater than the current PE for the GB Personal Products industry at 16.8x.
• The bearish analysts expect the number of shares outstanding to decline by 1.29% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 5.41%, as per the Simply Wall St company report.

Risks

• The rapid global rollout and strong initial consumer uptake of key product innovations such as Epicelline and Thiamidol, alongside Beiersdorf's proven ability to achieve market leadership in antiaging and dermocosmetic categories, may underpin robust sales and support revenue growth well above expectations.
  
• Beiersdorf's ability to regain shelf space and retailer support following pricing negotiations, combined with anticipated relisting and a significant portfolio of new launches in major markets, could drive a notable rebound in volume growth and help preserve or expand net margins.
  
• The company's strategic focus on premiumization, scientific innovation, and quick-to-market execution in both core and emerging markets is strengthening brand equity and average selling prices, providing resilience to financial pressures and supporting margin expansion in the medium to long term.
  
• Successes in digital channels and e-commerce, particularly in Asia (such as double-digit online growth for La Prairie in China and effective use of platforms like TikTok and JD.com), are increasing market reach, enabling Beiersdorf to tap into high-growth demographics and diversify revenue streams, which bodes well for long-term earnings potential.
  
• Ongoing investment in R&D, ambitious new category launches (for acne, antiaging, deodorants), and a climate of strong innovation-led growth in high-margin segments like Derma and Health Care are driving sustained outperformance versus competitors, positioning Beiersdorf to capture secular demand shifts and maintain healthy revenue and profit trajectories.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for Beiersdorf is €68.0, which represents up to two standard deviations below the consensus price target of €92.45. This valuation is based on what can be assumed as the expectations of Beiersdorf's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €170.0, and the most bearish reporting a price target of just €68.0.
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be €10.4 billion, earnings will come to €895.9 million, and it would be trading on a PE ratio of 18.7x, assuming you use a discount rate of 5.4%.
• Given the current share price of €72.3, the analyst price target of €68.0 is 6.3% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.